Increased dosage of epirubicin and mitomycin-C for the treatment of metastatic adenocarcinoma of unknown primary site
Polyzos, A.; Koulentianos, E.; Tzianoumis, L.; Sfikakis, P.
Journal of ChemoTherapy 1(4 Suppl): 1185-1186
1989
ISSN/ISBN: 1120-009X PMID: 16312826 Document Number: 340320
Document emailed within 1 workday
Related Documents
Sulkes, A.; Uziely, B.; Isacson, R.; Brufman, G.; Biran, S. 1988: Combination chemotherapy in metastatic tumors of unknown origin. 5-Fluorouracil, adriamycin and mitomycin C for adenocarcinomas and adriamycin, vinblastine and mitomycin C for anaplastic carcinomas Israel Journal of Medical Sciences 24(9-10): 604-610Greco, F.A.; Hainsworth, J.D. 1994: Poorly differentiated carcinoma or adenocarcinoma of unknown primary site: long-term results with cisplatin-based chemotherapy Seminars in Oncology 21(5 Suppl 12: 77-82
Hainsworth, J.D.; Greco, F.A. 1993: Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary tumor site Seminars in Oncology 20(3): 279-286
Hainsworth, J.D.; Johnson, D.H.; Greco, F.A. 1992: The role of cisplatin/bleomycin-based chemotherapy in the treatment of poorly differentiated carcinoma of unknown primary site Seminars in Oncology 19(2 Suppl 5: 54-57; Discussion 58
Hu, M.; Li, M.-H.; Kong, L.; Liu, N.-B.; Yang, G.-R.; Yu, J.-M. 2008: (18)F-FDG PET-CT in detecting the primary tumor in patients with metastatic cancers of unknown primary origin Zhonghua Zhong Liu Za Zhi 30(9): 699-701
Weissbach, L. 1992: Prospective randomized multicenter phase IIi study of treatment of hormone refractory prostatic cancer: mitomycin C vs. 4-epirubicin vs. estramustine phosphate Der Urologe. Ausg. a 31(1): 62
Hainsworth, J.D.; Greco, F.A. 1988: Managing carcinomas of unknown primary site Oncology 2(7): 43-49; 52-54
Le Cesne, A.; Le Chevalier, T.; Caille, P.; Cvitkovic, E.; Contesso, G.; Spielmann, M.; Rouesse, J. 1991: Metastases from cancers of unknown primary site. Data from 302 autopsies Presse Medicale 20(29): 1369-1373
Klein, P.; Prolla, G.; Wallach, R.; Melamed, J.; Muggia, F.M. 2000: BRCA1 germline mutation presenting as an adenocarcinoma of unknown primary Cancer Journal 6(3): 188-190
Lalowicz, I. 1988: Malignant neoplasms of unknown primary site with metastases to the bone marrow Polski Tygodnik Lekarski 43(22): 715-717
Leonard, R.J.; Nystrom, J.S. 1993: Diagnostic evaluation of patients with carcinoma of unknown primary tumor site Seminars in Oncology 20(3): 244-250
De Braud, F.; al-Sarraf, M. 1993: Diagnosis and management of squamous cell carcinoma of unknown primary tumor site of the neck Seminars in Oncology 20(3): 273-278
Jeremic, B.; Djuric, L.J.; Jevremovic, S.; Stanisavljevic, B.; Milojevic, L.J.; Mijatovic, L.J. 1992: Metastatic squamous cell carcinoma of an unknown primary tumor localized to the neck Journal of ChemoTherapy 4(1): 41-45
Csonka, C.; Ludmány, E. 1991: Primary adenocarcinoma at a colostomy site Orvosi Hetilap 132(31): 1709-1711
Vannetzel, J.M.; Colbert, N.; Laugier, A. 1985: Metastatic adenocarcinoma without known primary Annales de Medecine Interne 136(5): 423-429
Lück, H.J.; Thomssen, C.; du Bois, A.; Lisboa, B.W.; Untch, M.; Kühnle, H.; Jänicke, F.; Meerpohl, H.G.; Lindner, C.; Konecny, G.; Hecker, D.; Diergarten, K. 1997: Preliminary results of a phase Ii study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancer Seminars in Oncology 24(1 Suppl 3: S13-S16
Yamada, T.; Ohtsubo, K.; Ishikawa, D.; Nanjo, S.; Takeuchi, S.; Mouri, H.; Yamashita, K.; Yasumoto, K.; Yano, S. 2012: Cancer of unknown primary site with epidermal growth factor receptor mutation for which gefitinib proved effective Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(8): 1291-1294
Le Chevalier, T.; Cvitkovic, E.; Caille, P.; Harvey, J.; Contesso, G.; Spielmann, M.; Rouesse, J. 1988: Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients Archives of Internal Medicine 148(9): 2035-2039
Sage, R.A.; Miller, J.M.; Stuck, R.; Pinzur, M. 1994: The foot as a primary site for distant metastatic infection Journal of Foot and Ankle Surgery: Official Publication of the American College of Foot and Ankle Surgeons 33(6): 567-571
Yamamoto, K.; Ueno, T.; Ikeda, T.; Kosaba, S. 2000: A case of the cancer of an unknown primary site with elevated titer of serum CEA which was followed by the right sleeve upper lobectomy and mediastinal lymph node dissection Kyobu Geka. Japanese Journal of Thoracic Surgery 53(7): 605-607